Nevertheless, despite the many available studies reporting TGF-β involvement in CAF activation and PDAC progression and chemoresistance, the role of TGF-β in early PDAC remains controversial, as there is evidence for both tumor-promoting and suppressor activity [23,24,25]. Here, TGFB1 is linked to neoplasm.